ABAS OMAR: Open Payments
NPI 1952059750 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 6 payments from 5 companies in 2025. Trend: 2023 $49 · 2024 $162 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
Products named: XIFAXAN, CAPLYTA, TRINTELLIX, REXULTI, Ozempic.
Industry payments across NC — which companies pay providers there.
